| Literature DB >> 24388639 |
Duygu Ovunc Hacihamdioglu1, Murat Demiriz2, Gungor Sobaci3, Murat Kocaoglu4, Erkan Demirkaya5, Faysal Gok5.
Abstract
Behçet's disease (BD) is a multisystem disorder. The main pathology in BD is vasculitis that involves arteries and veins of all calibers. Central nervous system involvement occurs in 5-10% of patients. Increased morbidity and mortality is rarely observed in children. The mean age at onset in pediatric BD is approximately 7 years. Neurologic involvement in BD is usually observed after 3-6 years. We report the case of a four-year-old Turkish boy with BD with sagittal sinus thrombosis treated with infliximab. The patient presented papilledema without neurologic signs. Although long-term efficacy evaluations are needed in this case, infliximab therapy may be a good option in childhood BD with refractory sinus thrombosis. This is the youngest case of BD with sagittal sinus thrombosis reported so far.Entities:
Keywords: Behçet's disease; Children; Enfermedad de Behçet's; Infliximab; Niños; Thrombosis; Trombosis
Mesh:
Year: 2013 PMID: 24388639 DOI: 10.1016/j.reuma.2013.05.007
Source DB: PubMed Journal: Reumatol Clin ISSN: 1699-258X